Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axonex AI Group Limited - Class A Ordinary Shares (NQ:AXNX)

0.5615 -0.1485 (-20.92%)
Delayed Quote Updated: 12:03 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axonex AI Group Limited - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Earnings Scheduled For May 1, 2023 ↗
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
News headline image
Axonics Earnings Preview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 1, 2023 ↗
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
News headline image
Axonics to Participate in Upcoming Investor Conferences
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
From Axonics, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023 ↗
 
Via Benzinga
News headline image
Axonics Modulation Tech Earnings Preview ↗
 
Via Benzinga
Analyst Ratings for Axonics ↗
 
Via Benzinga
News headline image
2 Fast-Growing Healthcare Stocks to Buy and Hold ↗
The innovative companies have made great gains in a short period of time. 
Via The Motley Fool
News headline image
Axonics Posts Smaller Than Expected Quarterly Loss, Raises Guidance ↗
 
Via Benzinga
News headline image
Axonics to Report First Quarter 2023 Financial Results on May 1
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas
From Axonics, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023 ↗
 
Via Benzinga
News headline image
Analyst Ratings for Axonics ↗
Axonics (NASDAQ:AXNX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Axonics Risk/Reward Ratio Is Less Favorable, Analyst Says While Downgrading Stock ↗
Needham downgraded Axonics Inc (NASDAQ: AXNX) from Buy to Hold. 
Via Benzinga
News headline image
Axonics to Participate in the SUFU 2023 Winter Meeting
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
Axonics to Report Fourth Quarter 2022 Financial Results on March 1
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
News headline image
Why Axonics Shares Are Trading Higher Today? ↗
Axonics, Inc. (NASDAQ: AXNX) shares are trading higher after the company reported preliminary fourth-quarter and full-year 2022 total net revenue results above estimates. The company also issued FY23... 
Via Benzinga
News headline image
Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance
From Axonics, Inc.
Via Business Wire
News headline image
Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Axonics, Inc.
Via Business Wire
News headline image
Axonics Receives Health Canada Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
News headline image
Axonics® to Participate in the Piper Sandler Healthcare Conference
From Axonics, Inc.
Via Business Wire
News headline image
Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast 500™ List of the Fastest Growing Companies in North America
From Axonics, Inc.
Via Business Wire
News headline image
Axonics® Reports Third Quarter 2022 Financial Results
From Axonics, Inc.
Via Business Wire
News headline image
Earnings Scheduled For October 31, 2022 ↗
Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.